Clinical Trials Logo

Clinical Trial Summary

To evaluate the efficacy Cadonilimab in combination with Ramucirumab for the treatment of advanced Hepatocellular Carcinoma that has failed at systemic therapy


Clinical Trial Description

An open, single-arm, single-centre,Phase II clinical study evaluating Cadonilimab in combination with Ramucirumab for the treatment of advanced hepatocellular carcinoma that has failed at systemic therapy ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05856864
Study type Interventional
Source Tianjin Medical University Cancer Institute and Hospital
Contact Huikai Li, MD
Phone 18622228639
Email tjchlhk@126.com
Status Recruiting
Phase Phase 1
Start date June 1, 2024
Completion date May 1, 2025